Clinical Trials on Drug-Induced Hypersensitivity Syndrome in United Kingdom

Total 1336 results

Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Intensive Outpatient Versus Outpatient Treatment With Buprenorphine Among African Americans

Drug Dependence

United States
University of Chicago
National Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse...

Completed

Drug Effects on Preference and Reward

Drug Addiction

United States
University of Florida
National Institutes of Health (NIH)

Completed

Youth Drug Abuse Family and Cognitive-Behavioral Therapy

Drug Abuse

United States
Children's Hospital of Philadelphia
National Institute on Deafness and Other Communication Disorders (NIDCD); Monell...

Completed

Taste of Medicines in Children

Medication Adherence | Medication Reaction

United States
National Institute on Drug Abuse (NIDA)

Completed

Effect of Functional Genetic Polymorphisms on Brain Morphology and Function

Drug Abuse

United States
University of Chicago
INSYS Therapeutics Inc

Completed

Cannabidiol and Emotional Stimuli (CAS)

Drug Addiction

United States
National Institute on Drug Abuse (NIDA)

Completed

The Effects of Expectation on Natural and Drug -Induced Rewards

Drug Abuse

United States
National Institute on Drug Abuse (NIDA)

Completed

Automatic Versus Evaluative Components of Cue Reactivity

Drug Dependence

United States
National Institute on Drug Abuse (NIDA)

Completed

Reinforcement-Based Treatment and Abstinence-Contingent Housing for Drug Abusers (CASA)

Drug Abuse

United States
University of Michigan

Completed

Project Health Link: Connecting Patients With Services

Drug Abuse

United States
National Institute on Drug Abuse (NIDA)

Terminated

Oxytocin and Cognitive Behavioral Therapy in Drug Dependence

Drug Dependence

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

Treating the Partners of Drug Using Pregnant Women: Stage II (HOPE)

Drug Addiction

United States
University of Florida
National Institute on Drug Abuse (NIDA)

Withdrawn

Multiple Behavior Screening, Brief Intervention and Referral to Treatment (SBIRT) Model of Drug Abuse in Primary Care (SBIRT)

Drug Abuse

United States
National Center for Research Resources (NCRR)

Completed

Behavioral Economics of Human Drug Self-Administration

Drug Dependence

United States
Neurocrine Biosciences

Completed

The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine

Tardive Dyskinesia (TD)

United States, Puerto Rico
Chandrikha Chandrasekhara
TerSera Therapeutics LLC

Withdrawn

Prospective Assessment of Patients With Neuroendocrine Tumors and Current or Prior History of Carcinoid Syndrome or Diarrhea Undergoing Peptide Receptor Radionuclide Therapy With or Without Telotristat Ethyl (NET-PACS)

Diarrhea | Neuroendocrine Tumors | Carcinoid Syndrome

United States
Yale University
Health Resources and Services Administration (HRSA); The New York Academy of... and other collaborators

Completed

Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM) (BELIEVE)

HIV | Substance Abuse | Drug Abuse | Substance-related Disorders | Drug Addiction | Opiate Addiction | Drug Use Disorder | Buprenorphine | Drug Dependence | Drug Use Disorders

United States
University of Arkansas

Completed

Drug Discrimination in Methadone-Maintained Humans Study 1 (OMDD1)

Drug Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)

Active, not recruiting

CB1R in Synthetic Psychoactive Cannabinoids (CB1R in Spice)

Drug Dependence

United States
Friends Research Institute, Inc.

Completed

Computerized Brief Intervention vs. Delayed Computerized Brief Intervention

Drug Abuse

United States
University of California, Los Angeles

Completed

Homeless Female Offenders Returning to the Community (FEM-CARE)

Drug Addiction

United States
University of Arkansas
National Institute on Drug Abuse (NIDA)

Completed

Drug Discrimination in Methadone-Maintained Humans Study 3 (OMDD3)

Drug Dependence

United States
Addex Pharma S.A.

Recruiting

Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Parkinson Disease | Dyskinesias | Dyskinesia, Drug-Induced

United States
University of Missouri-Columbia

Completed

Methylnaltrexone vs Naloxegol in the Treatment of Opioid-Induced Constipation

Constipation Drug Induced

United States
Janssen Research & Development, LLC

Completed

Crossover Study to Evaluate the Abuse Potential of Intranasal Esketamine Compared to Racemic Intravenous Ketamine in Nondependent, Recreational Drug Users

Drug Abuse

United States
Massachusetts General Hospital
University of Colorado, Denver; Mayo Clinic; National Heart, Lung, and Blood... and other collaborators

Recruiting

Genetics of QT Prolongation With Antiarrhythmics (DOFEGEN)

Long QT Syndrome | Drug Toxicity

United States
Massachusetts General Hospital

Completed

Sonoelastography: Ultrasound Method to Measure Liver Fibrosis

Chronic Liver Disease | Non-Alcoholic Fatty Liver Disease | Drug-Induced Liver Injury | Hepatitis C Virus (HCV) Coinfection | Hepatitis B Virus (HBV)

United States
Lexicon Pharmaceuticals

Completed

Study of Telotristat Etiprate (LX1606) in Participants With Symptomatic Carcinoid Syndrome Not Managed by Stable-Dose Octreotide Therapy

Carcinoid Syndrome

United States
Friends Research Institute, Inc.
National Institute on Drug Abuse (NIDA)

Completed

Extended Release Naltrexone for Opioid-Dependent Youth

Drug Dependence

United States
National Institute on Alcohol Abuse and Alcoholism...

Completed

Brain Function in Response to Motivational Stimuli

Drug Dependence

United States
Wayne State University
National Institute on Drug Abuse (NIDA)

Completed

Indirect Assessment and Intervention for Perinatal Drug Use

Drug Abuse

United States
Harvard University
National Institute on Drug Abuse (NIDA)

Completed

Behavioral Couples Therapy for Female Drug-Abusing Patients (CPW-D)

Drug Abuse

United States
University of Chicago
National Institute on Drug Abuse (NIDA)

Completed

Effects of MDMA on Social and Emotional Processing

Drug Addiction

United States
University of Minnesota

Completed

Brief Intervention for Drug Abusing Adolescents

Drug Abuse

United States
Vistakon Pharmaceuticals

Completed

Safety Study of Ophthalmic Solution in Healthy, Normal Volunteers

Healthy Volunteers Eligible for Study; Drug Being Developed for Allergic Conjunctivitis

United States
Icagen

Completed

Study to Assess Safety and Efficacy of Oral Senicapoc Administration on Exercise-induced Asthma

Exercise Induced Asthma

United States
European Organisation for Research and Treatment...

Terminated

Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx

Head and Neck Cancer | Radiation Toxicity | Oral Complications | Drug/Agent Toxicity by Tissue/Organ

Spain, France, Belgium, Italy, United Kingdom, Turkey
University College, London

Unknown

TTP and aHUS in Complicated Pregnancies

Thrombotic Microangiopathies | Thrombotic Thrombocytopenic Purpura | Thrombocytopenia | Pre-Eclampsia | HELLP Syndrome | Stillbirth | Atypical Hemolytic Uremic Syndrome | IUGR

United Kingdom
AstraZeneca

Completed

Study in Healthy Volunteers to Investigate the Effects of Quinidine on the Pharmacokinetics of NKTR-118

Drug Induced Constipation

United States
Johns Hopkins University
National Institute on Drug Abuse (NIDA)

Completed

The Effect of Fetal Gender on Maternal Substance Abuse Treatment

Pregnancy | Drug Dependence

United States
Albany Medical College

Recruiting

No Opioids PrescrIptions On Discharge After Surgery (NOPIOiDS)

Postoperative Pain | Surgery | Opioid Use | Prescription Drug Abuse and Dependency

United States
Vinay Badhwar

Enrolling by invitation

Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL) (OPTIMAL)

Endocarditis

United States
UK Kidney Association

Recruiting

National Registry of Rare Kidney Diseases (RaDaR)

Vasculitis | AL Amyloidosis | Tuberous Sclerosis | Fabry Disease | Cystinuria | Focal Segmental Glomerulosclerosis | IgA Nephropathy | Bartter Syndrome | Pure Red Cell Aplasia | Membranous Nephropathy | Atypical Hemolytic Uremic Syndrome | Autosomal Dominant Polycystic Kidney Disease | Cystinosis | Nephronophthisis | BK Nephropathy and other conditions

United Kingdom
University of Utah
National Institute on Drug Abuse (NIDA); University of Cincinnati; Purdue University

Completed

Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool (PHARMSCREEN)

Opioid Abuse | Prescription Drug Abuse (Not Dependent)

United States
Tabula Rasa HealthCare

Enrolling by invitation

Simulation of Risk of Adverse Drug Events Associated With the Initiation of Drugs Repurposed for the Treatment of COVID-19 in Frail Elderly Adults With Polypharmacy

COVID | Drug Effect | Adverse Drug Event | Drug Interaction

United States
KalVista Pharmaceuticals, Ltd.

Completed

Phase 1 Crossover Study in Healthy Subjects to Evaluate the PK Profile of KVD824 Following Single and Multiple Doses of Modified Release (MR) Formulations

Hereditary Angioedema

United Kingdom
KalVista Pharmaceuticals, Ltd.

Completed

A Single Dose Safety, Tolerability, Pharmacokinetic and Food Effect Study of KVD900 in Healthy Volunteers

Hereditary Angioedema

United Kingdom
BioCryst Pharmaceuticals

Completed

A Relative Bioavailability Study of Two Formulations of BCX7353

Hereditary Angioedema

United Kingdom
BioCryst Pharmaceuticals

Completed

First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BCX7353 in Healthy Western and Japanese Volunteers

Hereditary Angioedema

United Kingdom
Cephalon

Completed

A Study to Assess the Abuse Potential of Hydrocodone Extended-Release Tablet in Recreational Opioid Users

Drug Abuse

United States, Canada

Clinical Trials on Drug-Induced Hypersensitivity Syndrome in United Kingdom

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Oman

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations